Efficacy of EMONO as an add-on Therapy to Conventional Antidepressants for the Treatment of Depressive Symptoms in Nursing-home Residents With Neurocognitive Disorders: a Randomized Controlled Trial-

NCT06382389 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

96

Enrollment

OTHER

Sponsor class

Conditions

Depression
Neurocognitive Disorders

Interventions

DRUG: EMONO
DRUG: Medical air

Sponsor

University Hospital, Tours